ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) presented as an active mover, shares eased up remains unchanged to traded at $23.95 in most recent trading session. The firm has floated short ratio of 13.51%, hold to candle to sentiment indicator of Short Ratio, its stand at 2.53. Efficiency or profitability analysis gives an …
February, 2017
-
14 February
ARIAD Pharmaceuticals (NASDAQ:ARIA)- Bullish Movers Gaining Investors Attention: Global Blood Therapeutics (NASDAQ:GBT)
Shares of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -0.17% to close at $23.85. . Moving forward to saw long-term intention, the experts calculate Return on Investment of -62.90%. The stock is going forward its fifty-two week low with 445.77% and …
-
7 February
Frontline Active Stocks in Broker Choice: ARIAD Pharmaceuticals (NASDAQ:ARIA), KKR & Co. (KKR)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] moved down reacts as active mover, shares a loss -0.04% to traded at $23.79 and the percentage gap between open changing to regular change was 0.00%. ARIAD Pharmaceuticals Inc. (ARIA) declared that submission of a Marketing Authorization Application (MAA) for its investigational oral anaplastic lymphoma …
-
5 February
ARIAD Pharmaceuticals (NASDAQ:ARIA)- Analysts Forecasting Profitability Indicators: PharmAthene (NYSE:PIP)
Under investment valuation analysis, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) presented as an active mover, it has floated short ration of 12.57%, hold to candle to sentiment indicator of Short Ratio, which was 2.21. Shares knocked up 0.04% to trade at $23.80 in most recent trading session. Ratio Analysis The co stands …
-
3 February
Most Bizarre Stocks for the Day: ARIAD Pharmaceuticals (NASDAQ:ARIA), Novavax (NASDAQ:NVAX)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) keeps its position active in context of investors’ investment valuation, price per shares reduced -0.13% to $23.79 with volume of 11.89 Million. Slightly noticeable ratio of firm is current ratio, which is standing at 3.20. Cambridge-based Ariad Pharmaceuticals has not told employees whether it plans to …
-
2 February
Stocks Getting Investors Vote of Confidence: ARIAD Pharmaceuticals (NASDAQ:ARIA), Array BioPharma (NASDAQ:ARRY)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) persists its position slightly strong in context of buying side, while shares price slightly down -0.13% during latest trading session. Narrow down focus to other ratios, the co has current ratio of 3.20 that indicates if ARIA lies in 1.3% to 3% then it is acceptable …
-
1 February
Hot Stocks Retreats on New Development: ARIAD Pharmaceuticals (NASDAQ:ARIA), BioScrip (NASDAQ:BIOS)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] knocking active thrust in leading trading session, shares an advance of 0.72% to 23.82 with around 14.67 Million shares have changed hands in this session. Lets us look over what analysts have to say about performance of the ARIA. Starting with EPS for the …
January, 2017
-
31 January
ARIAD Pharmaceuticals (NASDAQ:ARIA)- Healthcare Stocks Tumbling on Lethargic Results: Align Technology (NASDAQ:ALGN)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) runs in leading trade, it are moving down -0.13% to traded at $23.65. ARIA attains analyst recommendation of 2.70 on scale of 1-5 with week’s performance of -0.25%. ARIA is presenting price to cash flow of 14.60. Cambridge-based, Ariad Pharmaceuticals (ARIA0 has not told employees whether …
-
25 January
Two Stocks you Can Bet on: ARIAD Pharmaceuticals (NASDAQ:ARIA), Merrimack Pharmaceuticals (NASDAQ:MACK)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] retains strong position in active trade, as shares scoring 0.13% to $23.74 in a active trade session, while looking at the shares volume, around 11.68 Million shares have changed hands in this session. . The firm has institutional ownership of 88.00%, while insider ownership …
-
24 January
ARIAD Pharmaceuticals (NASDAQ:ARIA)- Stocks Regain Analysts Interests: Exact Sciences (NASDAQ:EXAS)
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -0.17% to 23.71 with around 9.14 Million shares have changed hands in this session. The ARIA held a rough session during the week but was ready to get some critical analysis. The stock …